← back to search

Richard Chudleigh

Swansea University · GB
Area of research
Infectious Diseases · Endocrinology, Diabetes and Metabolism
Research interest
Research focused on Diabetes mellitus and Type 2 diabetes, with related work in Semaglutide, Intensive care medicine, Diabetic ketoacidosis. Notable publications include 'Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study', '<p>Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data</p&gt', and 'Semaglutide injection for the treatment of adults with type 2 diabetes'.
h-index
citations
82
works
11
NIH funding
primary concept
email

Recent publications

Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies
Diabetes Therapy 2022cited by 4position: middledoi
Diabetes mellitus: what the neurologists need to know
Practical Neurology 2022cited by 2position: lastdoi
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study
Diabetes Therapy 2021cited by 31position: middledoi
A physician's approach and experience of managing patients with diabetes during <scp>COVID</scp>‐19
Practical Diabetes 2021cited by 2position: lastdoi
COVID-19 outcomes in people with diabetes in Wales: a secondary analysis of the ABCD audit
British Journal of Diabetes 2021cited by 0position: middledoi
&lt;p&gt;Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data&lt;/p&gt;
Diabetes Metabolic Syndrome and Obesity 2020cited by 22position: firstdoi
Semaglutide injection for the treatment of adults with type 2 diabetes
Expert Review of Clinical Pharmacology 2020cited by 11position: firstdoi
A very itchy rash in a young woman with type 1 diabetes
Diabetic Medicine 2020cited by 0position: lastdoi
Efficacy of newer agents in the glycaemic management of patients with type 2 diabetes
Current Medical Research and Opinion 2019cited by 3position: firstdoi
Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinic
Diabetes & Metabolic Syndrome Clinical Research & Reviews 2018cited by 4position: middledoi
A case series of DKA occurring in patients receiving treatment with SGLT‐2 inhibitors
Diabetes Obesity and Metabolism 2018cited by 3position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

David M. Williams · Swansea University5 papers (2018–2022)Jeffrey W. Stephens · Swansea Bay University Health Board5 papers (2018–2022)Stephen C. Bain · Swansea Bay University Health Board5 papers (2018–2021)Rajesh Peter · Swansea University2 papers (2018–2021)Thinzar Min · Swansea University2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2020–2021)Rajiv Gandhi · Centre for Human Genetics1 papers (2021–2021)Steve Baín · Swansea University1 papers (2019–2019)David E. Price · St Thomas' Hospital1 papers (2018–2018)Sam Rice · Swansea University1 papers (2021–2021) · 1 papers (2022–2022) · 1 papers (2021–2021) · 1 papers (2022–2022) · 1 papers (2021–2021) · 1 papers (2022–2022) · 1 papers (2021–2021)Emma G. Wilmot · University of Nottingham1 papers (2021–2021) · 1 papers (2021–2021)Maneesh Udiawar · Cardiff University1 papers (2021–2021)